Company Filing History:
Years Active: 2025
Title: Huining Liang: Innovator in EGFR Kinase Inhibition
Introduction
Huining Liang is a notable inventor based in Beijing, China. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target specific kinases involved in various diseases.
Latest Patents
Huining Liang holds a patent for a compound that inhibits and induces the degradation of EGFR kinase. This invention, described by the general formula (I), includes a pharmaceutical composition containing the inhibitor. The compound is particularly relevant for treating diseases associated with EGFR kinase, such as cancer. The patent also outlines the preparation and use of the inhibitor, showcasing its potential therapeutic applications.
Career Highlights
Liang is currently employed at Beijing Tide Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work focuses on innovative solutions in the pharmaceutical industry, contributing to the fight against serious health conditions.
Collaborations
Huining Liang collaborates with esteemed colleagues, including Yanping Zhao and Hongjun Wang. Their combined expertise enhances the research and development initiatives at their company.
Conclusion
Huining Liang's contributions to the field of EGFR kinase inhibition highlight his role as an influential inventor in the pharmaceutical industry. His work not only advances scientific knowledge but also holds promise for improving treatment options for patients with cancer and other related diseases.